Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Helix BioPharma Corp. Provides Update on Phase II/III IND Application for Topical Interferon Alpha-2b
Helix BioPharma Corp. Provides Update on Phase II/III IND Application for Topical Interferon Alpha-2b
Helix BioPharma Corp. Provides Update on Phase II/III IND Application for Topical Interferon Alpha-2b
Submitted by
admin
on November 20, 2010 - 12:46pm
Source:
MarketWatch
News Tags:
Helix BioPharma
topical interferon Alpha-2b
cervical lesions
cervical cancer
Headline:
Helix BioPharma Corp. Provides Update on Phase II/III IND Application for Topical Interferon Alpha-2b
Do Not Allow Advertisers to Use My Personal information
